First line therapy with Bendamustine in advanced indolent Non-Hodgkin Lymphoma in treatment routine – interim analysis of the non-interventional study Be-1st.

Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Grass, J., Straßl, L., 2011.

Onkologie 34 (suppl.6)(P891), 268. doi:10.1159/000333305

Studie: Be-1st; Indikation: Hämoblastosen; Jahr: 2011; Veranstaltung: DGHO; Journal: Onkologie

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com